---

Procedure

Percutaneous needle biopsy Endoscopic directed biopsy Adrenalectomy, total Adrenalectomy, partial Other Not specified

---

Specimen Laterality

Right Left Bilateral Not specified Other

---

Tumor Size (cm)

---

Tumor Weight (g)

---

Histologic Type

Adrenal cortical carcinoma Adrenal cortical carcinoma, oncocytic type Adrenal cortical carcinoma, myxoid type Adrenal cortical carcinoma, sarcomatoid type

---

Histologic Grade

Low grade (≤20 mitoses/50 high-power fields) High grade (>20 mitoses/50 high-power fields) Cannot be assessed, insufficent tumor, <50 hpf to count Cannot be assessed

---

Lymphovascular Invasion tool

Not identified Large vessel invasion, renal vein Large vessel invasion, vena cava Large vessel invasion, not otherwise specified Microscopic angioinvasion Lymphatic invasion Cannot be determined

---

Tumor Extension (select all that apply)

No evidence of primary tumor Tumor confined to adrenal cortex without invasion through tumor capsule (if present) Tumor invades into or through the adrenal capsule Tumor invades into extra-adrenal structures Tumor invades into adjacent organs Cannot be assessed

---

Margins

Cannot be assessed Uninvolved by tumor Involved by tumor Not applicable

---

Regional Lymph Nodes

Check here if any lymph nodes submitted?

---

Pathologic Staging (pTNM)

TNM Descriptors (select all that apply)

Not applicable m r y

pT

pTX: Primary tumor cannot be assessed pT0: No evidence of primary tumor pT1: Tumor ≤5 cm in greatest dimension, no extra-adrenal invasion pT2: Tumor >5 cm, no extra-adrenal invasion pT3: Tumor of any size with local invasion but not invading adjacent organs pT4: Tumor of any size that invades adjacent organs or large blood vessels

pN

pNX: Regional lymph nodes cannot be assessed pN0: No regional lymph node metastasis pN1: Metastasis in regional lymph node(s)

pM

pMx: Not applicable pM1: Distant metastasis

---

+ Additional Pathologic Findings

None identified Hemorrhage Cystic change Calcifications Other

---

+ Functional Status (select all that apply

Urinary 17-ketosteroids increased Cushing syndrome Conn syndrome Virilization Feminization Weight loss Other Not applicable

---

+ Ki67 proliferaiton index (%)